Johnson & Johnson seeks FDA authorization of COVID booster shot

NEW YORK — Johnson & Johnson announced on Tuesday it had submitted data to the U.S. Food and Drug Administration for emergency use authorization of a booster shot of its Covid-19 vaccine in people ages 18 years and older. While scientists are divided over the need for booster shots when so many people in the